274
Participants
Start Date
February 8, 2024
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
Piflufolastat F 18 Intravenous Solution [PYLARIFY]
Participants will receive a single dose of 333 MBq (9 mCi) \[296 MBq-370 MBq (8 mCi - 10 mCi)\] PYLARIFY injection followed by a single whole-body PET/CT or PET/MRI scan acquired at 1 to 2 hours post-dosing
Johns Hopkins University, Baltimore
Emory University, Atlanta
University of Alabama at Birmingham, Birmingham
Cleveland Clinic, Cleveland
Karmanos Cancer Institute Wayne State University, Detroit
BAMF Health, Grand Rapids
University of Iowa Health Care, Iowa City
Washington University School of Medicine, St Louis
Huntsman Cancer Institute University of Utah, Salt Lake City
Tower Urology, Los Angeles
Hoag Cancer Center, Irvine
University of California San Francisco, San Francisco
Oregon Health & Science University, Portland
Massachusetts General Hospital, Boston
Lead Sponsor
Lantheus Medical Imaging
INDUSTRY